Empirico
Empirico is a biotechnology company that powers therapeutic discovery with human genetics and small interfering RNA (siRNA) medicines. Combining internal capabilities in human genetics and siRNA chemistry with partner expertise, the company identifies naturally occurring genetic variations associated with health benefits and develops precision oligonucleotide therapeutics for common diseases with significant unmet medical need. In October 2024 Empirico entered a licensing agreement with GSK worth up to $745 million for a clinical-stage oligonucleotide targeting respiratory disease (COPD). Empirico is backed by DCVC. It is a pharmaceutical R&D company and does not operate a public technology or API platform.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
Empirico is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Empirico scores 11.9/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Resources
Every other property we hold for Empirico — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Commercial 2
Pricing, plans, and the legal terms of use
Company 5
The organization behind the API
Empirico is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/empirico · machine-readable index on apis.io